MEV for Retroclavicular Approach to Infraclavicular Block

Antalya Training and Research Hospital

Status: Terminated

Conditions: Bupivacaine

Treatments: Other: minimum effective volume

Study type: Observational

Funder types: Other

Identifiers

NCT03555786

AntalyaTRH25

Details and patient eligibility

About

In this study, the primary objective was to estimate the minimum effective volume of bupivacaine 0.5% resulting in successful block in 90% of patients (MEV90) for ultrasound-guided retroclavicular approach to infraclavicular brachial plexus block.

Full description

A "biased coin up-and-down sequential design" will be applied to assess the minimum effective volume in 90% of patients for the retroclavicular brachial plexus block. The first subject received 25 ml 0.5% bupivacaine . Each subsequent patient received a dose that depended on the response of the previous one. If the previous block is successful, the block will be performed either by a reduction of the volume by 2.5 ml with a probability ß = 0.11 or by a same dose of the previous one with a probability 1-ß = 0.89 in the next patient.

Enrollment: 45 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who received infraclavicular brachial plexus block for elective elbow, forearm, wrist, or hand surgery
• American Society of Anesthesiologists class I, II or III

Exclusion criteria

• patients <18 years old
• >65 years old
• body mass index (BMI) <20 or >35 kg/m2
• inability to provide written informed consent
• refusal of regional anesthesia
• pregnancy
• contraindication for regional anesthesia